pharma

the limitations of traditional feasibility in clinical trials

The 3 Reasons Why Traditional Feasibility is Not Enough When Planning Clinical Trials

When planning a clinical trial, selecting the right location is just as crucial as timing your drug’s release. We’ve observed over the years that more than traditional feasibility alone is needed to secure a successful trial. So, what’s the essential component we’re overlooking? Tick-Tock, Watch the Clock: Time is of …

The 3 Reasons Why Traditional Feasibility is Not Enough When Planning Clinical Trials Read More »

What Is Patient Feasibility and How Does It Differ From Patient Recruitment?

Everyone involved in the planning and running of clinical trials has heard of country and site feasibility. Selecting the right countries and partnering with the right hospitals and investigators can impact your trial profoundly – it can be the difference between smooth recruitment and a failed study. Country and site …

What Is Patient Feasibility and How Does It Differ From Patient Recruitment? Read More »

Country and Site Selection for Clinical Trials Need to Change. What Is Driving the Shift?

I am truly glad to be part of this clinical research community that looks for opportunities and drives for excellence and innovation. Thanks to multiple conversations with my network of experts I can see signs of change. And because I believe that change comes from people, I am writing this …

Country and Site Selection for Clinical Trials Need to Change. What Is Driving the Shift? Read More »

Planning a Clinical Trial: 3 Factors CROs Consider That Sponsors Rarely Do

Clinical Research Organizations (CRO) are the experts in clinical trial feasibility and the go-to-partner for helping biotech and pharma companies research, evaluate and launch their novel compound or medical device. And in fact, the CRO market has been growing in the last few years and is expected to reach $44bln …

Planning a Clinical Trial: 3 Factors CROs Consider That Sponsors Rarely Do Read More »

2 Reasons Big Pharma Companies Like Novartis And Bayer Plan Their Clinical Trials Internally

Big Pharma’s R&D is a daily focus and their huge pipeline requires careful consideration. This includes, of course, the clinical research section. In fact, even Big Pharma relies on Clinical Research Organisations (CRO) to run their clinical trials – at least in part. In the last few months, I spent …

2 Reasons Big Pharma Companies Like Novartis And Bayer Plan Their Clinical Trials Internally Read More »

Scroll to Top